Michael Aman - Publications

Affiliations: 
Psychology Ohio State University, Columbus, Columbus, OH 
Area:
Physiological Psychology

207 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Pearson DA, Santos CW, Aman MG, Arnold LE, Lane DM, Loveland KA, Mansour R, Ward AR, Casat CD, Jerger S, Schachar RJ, Bukstein OG, Cleveland LA. Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 32644833 DOI: 10.1089/cap.2020.0004  0.36
2020 Johnstone JM, Leung BMY, Srikanth P, Hatsu I, Perez L, Gracious B, Tost G, Aman MG, Gadow KD, Findling RL, Bukstein O, Arnold LE. Development of a Composite Primary Outcome Score for Children with Attention-Deficit/Hyperactivity Disorder and Emotional Dysregulation. Journal of Child and Adolescent Psychopharmacology. PMID 32101469 DOI: 10.1089/cap.2019.0179  0.36
2019 Grondhuis SN, Farmer CA, Arnold LE, Gadow KD, Findling RL, Molina BSG, Kolko DJ, Buchan-Page KA, Rice RR, Butter EM, Aman MG. Standardized Observation Analogue Procedure in the Treatment of Severe Childhood Aggression Study. Journal of Child and Adolescent Psychopharmacology. PMID 31730370 DOI: 10.1089/cap.2019.0109  0.6
2019 Bangerter A, Ness S, Lewin D, Aman MG, Esbensen AJ, Goodwin MS, Dawson G, Hendren R, Leventhal B, Shic F, Opler M, Ho KF, Pandina G. Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 30888551 DOI: 10.1007/s10803-019-03965-7  0.44
2019 Scahill L, Lecavalier L, Schultz RT, Evans AN, Maddox B, Pritchett J, Herrington J, Gillespie S, Miller J, Amoss RT, Aman MG, Bearss K, Gadow K, Edwards MC. Development of the Parent-Rated Anxiety Scale for Youth with Autism Spectrum Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 30797036 DOI: 10.1016/j.jaac.2018.10.016  0.32
2018 Joseph HM, Farmer C, Kipp H, Kolko D, Aman M, McGinley J, Arnold LE, Gadow KD, Findling RL, Molina BSG. Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression. Journal of Child and Adolescent Psychopharmacology. PMID 30592635 DOI: 10.1089/cap.2018.0119  0.36
2018 Lecavalier L, McCracken CE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Smith T, Johnson C, King B, Handen B, Swiezy NB, Eugene Arnold L, Bearss K, Vitiello B, Scahill L. An exploration of concomitant psychiatric disorders in children with autism spectrum disorder. Comprehensive Psychiatry. 88: 57-64. PMID 30504071 DOI: 10.1016/j.comppsych.2018.10.012  0.32
2018 Barrie ES, Pinsonneault JK, Sadee W, Hollway JA, Handen BL, Smith T, Arnold LE, Butter E, Hansen-Kiss E, Herman GE, Aman MG. Testing genetic modifiers of behavior and response to atomoxetine in autism spectrum disorder with ADHD. Journal of Developmental and Physical Disabilities. 30: 355-371. PMID 30197492 DOI: 10.1007/s10882-018-9590-4  0.6
2018 Aman MG, Arnold LE, Barterian JA. Clinical Relevance Versus Statistical Significance: Aman and Colleagues Respond to Editorial. Journal of the American Academy of Child and Adolescent Psychiatry. 57: 352-353. PMID 29706166 DOI: 10.1016/j.jaac.2017.12.012  0.36
2018 Arnold LE, Ober N, Aman MG, Handen B, Smith T, Pan X, Hyman SL, Hollway J, Lecavalier L, Page K, Rice R. A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism. Journal of Child and Adolescent Psychopharmacology. PMID 29694241 DOI: 10.1089/cap.2017.0134  0.36
2018 Aman MG, Hollway JA, Veenstra-VanderWeele J, Handen BL, Sanders KB, Chan J, Macklin E, Arnold LE, Wong T, Newsom C, Hastie Adams R, Marler S, Peleg N, Anagnostou EA. Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use. Journal of Child and Adolescent Psychopharmacology. PMID 29620914 DOI: 10.1089/cap.2017.0072  0.6
2017 Barterian JA, Arnold LE, Brown NV, Farmer CA, Williams C, Findling RL, Kolko DJ, Bukstein OG, Molina BSG, Townsend L, Aman MG. Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings. Journal of the American Academy of Child and Adolescent Psychiatry. 56: 1026-1033. PMID 29173736 DOI: 10.1016/j.jaac.2017.09.426  0.36
2017 Hollway JA, Mendoza-Burcham M, Andridge R, Aman MG, Handen B, Arnold LE, Lecavalier L, Williams C, Silverman L, Smith T. Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 29112459 DOI: 10.1089/cap.2017.0085  0.6
2017 Lecavalier L, Pan X, Smith T, Handen BL, Arnold LE, Silverman L, Tumuluru RV, Hollway J, Aman MG. Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 29022125 DOI: 10.1007/s10803-017-3345-4  0.36
2017 Handen BL, Anagnostou E, Aman MG, Sanders KB, Chan J, Hollway JA, Brian J, Arnold LE, Capano L, Williams C, Hellings JA, Butter E, Mankad D, Tumuluru R, Kettel J, et al. A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension. Journal of the American Academy of Child and Adolescent Psychiatry. 56: 849-856.e6. PMID 28942807 DOI: 10.1016/j.jaac.2017.07.790  0.6
2017 Tumuluru RV, Corbett-Dick P, Aman MG, Smith T, Arnold LE, Pan X, Buchan-Page KA, Brown NV, Ryan MM, Hyman SL, Hellings J, Williams C, Hollway JA, Lecavalier L, Rice RR, et al. Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism. Journal of Child and Adolescent Psychopharmacology. PMID 28509573 DOI: 10.1089/cap.2016.0187  0.6
2017 Bangerter A, Ness S, Aman MG, Esbensen AJ, Goodwin MS, Dawson G, Hendren R, Leventhal B, Khan A, Opler M, Harris A, Pandina G. Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 28498053 DOI: 10.1089/cap.2017.0018  0.44
2017 Criado KK, Sharp WG, McCracken CE, De Vinck-Baroody O, Dong L, Aman MG, McDougle CJ, McCracken JT, Eugene Arnold L, Weitzman C, Leventhal JM, Vitiello B, Scahill L. Overweight and obese status in children with autism spectrum disorder and disruptive behavior. Autism : the International Journal of Research and Practice. 1362361316683888. PMID 28325061 DOI: 10.1177/1362361316683888  0.32
2017 Findling RL, Townsend L, Brown NV, Arnold LE, Gadow KD, Kolko DJ, McNamara NK, Gary DS, Kaplin DB, Farmer CA, Kipp H, Williams C, Butter EM, Bukstein OG, Rice R, ... ... Aman MG, et al. The Treatment of Severe Childhood Aggression Study: 12 Weeks of Extended, Blinded Treatment in Clinical Responders. Journal of Child and Adolescent Psychopharmacology. 27: 52-65. PMID 28212067 DOI: 10.1089/cap.2016.0081  0.36
2016 Lecavalier L, Smith T, Johnson C, Bearss K, Swiezy N, Aman MG, Sukhodolsky DG, Deng Y, Dziura J, Scahill L. Moderators of Parent Training for Disruptive Behaviors in Young Children with Autism Spectrum Disorder. Journal of Abnormal Child Psychology. PMID 27917460 DOI: 10.1007/s10802-016-0233-x  0.32
2016 Scahill L, Bearss K, Sarhangian R, McDougle CJ, Arnold LE, Aman MG, McCracken JT, Tierney E, Gillespie S, Postorino V, Vitiello B. Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 27893955 DOI: 10.1089/cap.2016.0107  0.36
2016 Vo LC, Snyder C, McCracken C, McDougle CJ, McCracken JT, Aman MG, Tierney E, Arnold LE, Levi D, Kelleman M, Carroll D, Morrissey J, Vitiello B, Scahill L. No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 27726426 DOI: 10.1089/cap.2016.0090  0.36
2016 Smith T, Aman MG, Arnold LE, Silverman LB, Lecavalier L, Hollway J, Tumuluru R, Hyman SL, Buchan-Page KA, Hellings J, Rice RR, Brown NV, Pan X, Handen BL. Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 868-876.e2. PMID 27663942 DOI: 10.1016/j.jaac.2016.06.015  1
2016 Anagnostou E, Aman MG, Handen BL, Sanders KB, Shui A, Hollway JA, Brian J, Arnold LE, Capano L, Hellings JA, Butter E, Mankad D, Tumuluru R, Kettel J, Newsom CR, et al. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 27556593 DOI: 10.1001/jamapsychiatry.2016.1232  0.6
2016 Farmer CA, Epstein JN, Findling RL, Gadow KD, Arnold LE, Kipp H, Kolko DJ, Butter E, Schneider J, Bukstein OG, McNamara NK, Molina BS, Aman MG. Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory. Journal of Child and Adolescent Psychopharmacology. PMID 27348211 DOI: 10.1089/cap.2016.0040  0.4
2016 Scahill L, Bearss K, Lecavalier L, Smith T, Swiezy N, Aman MG, Sukhodolsky DG, McCracken C, Minshawi N, Turner K, Levato L, Saulnier C, Dziura J, Johnson C. Effect of Parent Training on Adaptive Behavior in Children With Autism Spectrum Disorder and Disruptive Behavior: Results of a Randomized Trial. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 602-609.e3. PMID 27343887 DOI: 10.1016/j.jaac.2016.05.001  1
2016 Johnson CR, DeMand A, Lecavalier L, Smith T, Aman M, Foldes E, Scahill L. Psychometric properties of the children's sleep habits questionnaire in children with autism spectrum disorder. Sleep Medicine. 20: 5-11. PMID 27318219 DOI: 10.1016/j.sleep.2015.12.005  0.32
2016 Gadow KD, Brown NV, Arnold LE, Buchan-Page KA, Bukstein OG, Butter E, Farmer CA, Findling RL, Kolko DJ, Molina BS, Rice RR, Schneider J, Aman MG. Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 469-78. PMID 27238065 DOI: 10.1016/j.jaac.2016.03.014  0.4
2016 Scahill L, Jeon S, Boorin SJ, McDougle CJ, Aman MG, Dziura J, McCracken JT, Caprio S, Arnold LE, Nicol G, Deng Y, Challa SA, Vitiello B. Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 415-23. PMID 27126856 DOI: 10.1016/j.jaac.2016.02.016  1
2016 Hollway JA, Aman MG, Mendoza-Burcham MI, Silverman L, Arnold LE, Tumuluru R, Handen BL, Lecavalier L, Page K, Sayre P, Smith T. Caregiver Satisfaction with a Multisite Trial of Atomoxetine and Parent Training for Attention-Deficit/Hyperactivity Disorder and Behavioral Noncompliance in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 26797318 DOI: 10.1089/cap.2015.0130  0.6
2016 Farmer CA, Kaat AJ, Mazurek MO, Lainhart JE, DeWitt MB, Cook EH, Butter EM, Aman MG. Confirmation of the Factor Structure and Measurement Invariance of the Children's Scale of Hostility and Aggression: Reactive/Proactive in Clinic-Referred Children with and without Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 26744772 DOI: 10.1089/cap.2015.0098  1
2015 Handen BL, Aman MG, Arnold LE, Hyman SL, Tumuluru RV, Lecavalier L, Corbett-Dick P, Pan X, Hollway JA, Buchan-Page KA, Silverman LB, Brown NV, Rice RR, Hellings J, Mruzek DW, et al. Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 54: 905-15. PMID 26506581 DOI: 10.1016/j.jaac.2015.08.013  1
2015 Kaat A, Farmer C, Gadow K, Findling RL, Bukstein O, Arnold LE, Bangalore S, McNamara N, Aman M. Factor Validity of a Proactive and Reactive Aggression Rating Scale. Journal of Child and Family Studies. 24: 2734-2744. PMID 26504369 DOI: 10.1007/s10826-014-0075-5  0.36
2015 Bearss K, Taylor CA, Aman MG, Whittemore R, Lecavalier L, Miller J, Pritchett J, Green B, Scahill L. Using qualitative methods to guide scale development for anxiety in youth with autism spectrum disorder. Autism : the International Journal of Research and Practice. PMID 26395234 DOI: 10.1177/1362361315601012  1
2015 Calarge CA, Ziegler EE, Del Castillo N, Aman M, McDougle CJ, Scahill L, McCracken JT, Arnold LE. Iron homeostasis during risperidone treatment in children and adolescents. The Journal of Clinical Psychiatry. PMID 26301448 DOI: 10.4088/JCP.14m09258  1
2015 Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, et al. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 25: 482-93. PMID 26262903 DOI: 10.1089/cap.2015.0005  1
2015 Chowdhury M, Aman MG, Lecavalier L, Smith T, Johnson C, Swiezy N, McCracken JT, King B, McDougle CJ, Bearss K, Deng Y, Scahill L. Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder. Autism : the International Journal of Research and Practice. PMID 26187059 DOI: 10.1177/1362361315593941  0.32
2015 Aman MG, Arnold LE, Hollway JA. Assessing change in core autism symptoms: challenges for pharmacological studies. Journal of Child and Adolescent Psychopharmacology. 25: 282-5. PMID 25978740 DOI: 10.1089/cap.2015.28999.mga  1
2015 Bearss K, Johnson C, Smith T, Lecavalier L, Swiezy N, Aman M, McAdam DB, Butter E, Stillitano C, Minshawi N, Sukhodolsky DG, Mruzek DW, Turner K, Neal T, Hallett V, et al. Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial. Jama. 313: 1524-33. PMID 25898050 DOI: 10.1001/jama.2015.3150  1
2015 Rundberg-Rivera EV, Townsend LD, Schneider J, Farmer CA, Molina BB, Findling RL, Gadow KD, Bukstein OG, Arnold LE, Kolko DJ, Buchan-Page KA, McNamara NK, Michel C, Austin A, Kipp H, ... ... Aman MG, et al. Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression. Journal of Child and Adolescent Psychopharmacology. 25: 225-33. PMID 25885012 DOI: 10.1089/cap.2014.0097  1
2015 Farmer CA, Brown NV, Gadow KD, Arnold LE, Kolko DG, Findling RL, Molina BS, Buchan-Page KA, Rice RR, Bangalore SS, Bukstein O, Rundberg-Rivera EV, McNamara N, Aman MG. Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 25: 213-24. PMID 25885011 DOI: 10.1089/cap.2014.0109  1
2015 Arnold LE, Gadow KD, Farmer CA, Findling RL, Bukstein O, Molina BS, Brown NV, Li X, Rundberg-Rivera EV, Bangalore S, Buchan-Page K, Hurt EA, Rice R, McNamara NK, Aman MG. Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response. Journal of Child and Adolescent Psychopharmacology. 25: 203-12. PMID 25885010 DOI: 10.1089/cap.2014.0104  1
2015 Aman MG. Treatment of Severe Childhood Aggression (TOSCA) Studies. Journal of Child and Adolescent Psychopharmacology. 25: 201-2. PMID 25885009 DOI: 10.1089/cap.2015.2532  1
2015 Scahill L, Sukhodolsky DG, Anderberg E, Dimitropoulos A, Dziura J, Aman MG, McCracken J, Tierney E, Hallett V, Katz K, Vitiello B, McDougle C. Sensitivity of the modified Children's Yale-Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials. Autism : the International Journal of Research and Practice. PMID 25882391 DOI: 10.1177/1362361315574889  1
2015 Hellings JA, Reed G, Cain SE, Zhou X, Barth FX, Aman MG, Palaguachi GI, Mikhnev D, Teng R, Andridge R, Logan M, Butler MG, Han JC. Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability. Journal of Child and Adolescent Psychopharmacology. 25: 150-9. PMID 25782098 DOI: 10.1089/cap.2014.0003  1
2015 Pouget JG, Gonçalves VF, Nurmi EL, P Laughlin C, Mallya KS, McCracken JT, Aman MG, McDougle CJ, Scahill L, Misener VL, Tiwari AK, Zai CC, Brandl EJ, Felsky D, Leung AQ, et al. Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes. Pharmacogenomics. 16: 5-22. PMID 25560467 DOI: 10.2217/pgs.14.158  1
2015 Farmer C, Butter E, Mazurek MO, Cowan C, Lainhart J, Cook EH, DeWitt MB, Aman M. Aggression in children with autism spectrum disorders and a clinic-referred comparison group. Autism : the International Journal of Research and Practice. 19: 281-91. PMID 24497627 DOI: 10.1177/1362361313518995  1
2015 Scahill L, Aman MG, Lecavalier L, Halladay AK, Bishop SL, Bodfish JW, Grondhuis S, Jones N, Horrigan JP, Cook EH, Handen BL, King BH, Pearson DA, McCracken JT, Sullivan KA, et al. Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder. Autism : the International Journal of Research and Practice. 19: 38-52. PMID 24259748 DOI: 10.1177/1362361313510069  1
2014 Silverman L, Hollway JA, Smith T, Aman MG, Arnold LE, Pan X, Li X, Handen BL. A Multisite Trial of Atomoxetine and Parent Training in Children with Autism Spectrum Disorders: Rationale and Design Challenges. Research in Autism Spectrum Disorders. 8: 899-907. PMID 25197320 DOI: 10.1016/j.rasd.2014.03.013  1
2014 Matlock ST, Aman MG. Psychometric characteristics of the adult scale of hostility and aggression: reactive/proactive (A-SHARP) and relation to psychiatric features of adults with developmental disabilities. Research in Developmental Disabilities. 35: 3199-207. PMID 25155742 DOI: 10.1016/j.ridd.2014.07.029  1
2014 Gadow KD, Arnold LE, Molina BS, Findling RL, Bukstein OG, Brown NV, McNamara NK, Rundberg-Rivera EV, Li X, Kipp HL, Schneider J, Farmer CA, Baker JL, Sprafkin J, Rice RR, ... ... Aman MG, et al. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 948-959.e1. PMID 25151418 DOI: 10.1016/j.jaac.2014.05.008  1
2014 Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, Hyman SL, Mendoza-Burcham M, Pan X, Mruzek DW, Lecavalier L, Levato L, Silverman LB, Handen B. A review of atomoxetine effects in young people with developmental disabilities. Research in Developmental Disabilities. 35: 1412-24. PMID 24732041 DOI: 10.1016/j.ridd.2014.03.006  1
2014 Scahill L, Dimitropoulos A, McDougle CJ, Aman MG, Feurer ID, McCracken JT, Tierney E, Pu J, White S, Lecavalier L, Hallett V, Bearss K, King B, Arnold LE, Vitiello B. Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 97-107.e1. PMID 24342389 DOI: 10.1016/j.jaac.2013.09.018  0.36
2014 Aman MG, Bukstein OG, Gadow KD, Arnold LE, Molina BS, McNamara NK, Rundberg-Rivera EV, Li X, Kipp H, Schneider J, Butter EM, Baker J, Sprafkin J, Rice RR, Bangalore SS, et al. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder? Journal of the American Academy of Child and Adolescent Psychiatry. 53: 47-60.e1. PMID 24342385 DOI: 10.1016/j.jaac.2013.09.022  1
2014 Carroll D, Hallett V, McDougle CJ, Aman MG, McCracken JT, Tierney E, Arnold LE, Sukhodolsky DG, Lecavalier L, Handen BL, Swiezy N, Johnson C, Bearss K, Vitiello B, Scahill L. Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. Child and Adolescent Psychiatric Clinics of North America. 23: 57-72. PMID 24231167 DOI: 10.1016/j.chc.2013.08.002  1
2014 Kaat AJ, Lecavalier L, Aman MG. Validity of the aberrant behavior checklist in children with autism spectrum disorder. Journal of Autism and Developmental Disorders. 44: 1103-16. PMID 24165702 DOI: 10.1007/s10803-013-1970-0  1
2014 Lecavalier L, Wood JJ, Halladay AK, Jones NE, Aman MG, Cook EH, Handen BL, King BH, Pearson DA, Hallett V, Sullivan KA, Grondhuis S, Bishop SL, Horrigan JP, Dawson G, et al. Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder. Journal of Autism and Developmental Disorders. 44: 1128-43. PMID 24158679 DOI: 10.1007/s10803-013-1974-9  1
2014 Grondhuis SN, Aman MG. Overweight and obesity in youth with developmental disabilities: a call to action. Journal of Intellectual Disability Research : Jidr. 58: 787-99. PMID 24020517 DOI: 10.1111/jir.12090  1
2013 Pearson DA, Santos CW, Aman MG, Arnold LE, Casat CD, Mansour R, Lane DM, Loveland KA, Bukstein OG, Jerger SW, Factor P, Vanwoerden S, Perez E, Cleveland LA. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms. Journal of Child and Adolescent Psychopharmacology. 23: 337-51. PMID 23782128 DOI: 10.1089/cap.2012.0096  1
2013 Bearss K, Lecavalier L, Minshawi N, Johnson C, Smith T, Handen B, Sukhodolsky D, Aman M, Swiezy N, Butter E, Scahill L. Toward an exportable parent training program for disruptive behaviors in autism spectrum disorders. Neuropsychiatry. 3: 169-180. PMID 23772233 DOI: 10.2217/npy.13.14  1
2013 Handen BL, Johnson CR, Butter EM, Lecavalier L, Scahill L, Aman MG, McDougle CJ, Arnold LE, Swiezy NB, Sukhodolsky DG, Mulick JA, White SW, Bearss K, Hollway JA, Stigler KA, et al. Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders. Journal of Developmental and Physical Disabilities. 25: 355-371. PMID 23730123 DOI: 10.1007/s10882-012-9316-y  1
2013 Hollway JA, Aman MG, Butter E. Correlates and risk markers for sleep disturbance in participants of the Autism Treatment Network. Journal of Autism and Developmental Disorders. 43: 2830-43. PMID 23624832 DOI: 10.1007/s10803-013-1830-y  1
2013 Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, et al. Exploring the manifestations of anxiety in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. 43: 2341-52. PMID 23400347 DOI: 10.1007/s10803-013-1775-1  1
2013 Arnold LE, Anand R, Aman M. Varenicline in autistic disorder: hypothesis and case report of single-patient crossover. Journal of Child and Adolescent Psychopharmacology. 23: 61-4. PMID 23350866 DOI: 10.1089/cap.2012.0025  1
2013 Scahill L, Hallett V, Aman MG, McDougle CJ, Eugene Arnold L, McCracken JT, Tierney E, Deng Y, Dziura J, Vitiello B. Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials. Journal of Autism and Developmental Disorders. 43: 739-46. PMID 23104617 DOI: 10.1007/s10803-012-1689-3  0.32
2013 Farmer CA, Aman MG. Pharmacological Intervention for Disruptive Behaviors in Intellectual and Developmental Disabilities: The Glass is Half Full International Review of Research in Developmental Disabilities. 44: 281-325. DOI: 10.1016/B978-0-12-401662-0.00009-9  1
2012 Arnold LE, Aman MG, Li X, Butter E, Humphries K, Scahill L, Lecavalier L, McDougle CJ, Swiezy NB, Handen B, Wilson K, Stigler KA. Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry. 51: 1173-84. PMID 23101743 DOI: 10.1016/j.jaac.2012.08.028  0.4
2012 Pearson DA, Aman MG, Arnold LE, Lane DM, Loveland KA, Santos CW, Casat CD, Mansour R, Jerger SW, Ezzell S, Factor P, Vanwoerden S, Ye E, Narain P, Cleveland LA. High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology. 22: 284-91. PMID 22849541 DOI: 10.1089/cap.2011.0067  1
2012 Arnold LE, Aman MG, Hollway J, Hurt E, Bates B, Li X, Farmer C, Anand R, Thompson S, Ramadan Y, Williams C. Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology. 22: 198-205. PMID 22537359 DOI: 10.1089/cap.2011.0056  1
2012 Scahill L, McDougle CJ, Aman MG, Johnson C, Handen B, Bearss K, Dziura J, Butter E, Swiezy NG, Arnold LE, Stigler KA, Sukhodolsky DD, Lecavalier L, Pozdol SL, Nikolov R, et al. Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. Journal of the American Academy of Child and Adolescent Psychiatry. 51: 136-46. PMID 22265360 DOI: 10.1016/j.jaac.2011.11.010  1
2012 Farmer C, Lecavalier L, Yu S, Eugene Arnold L, McDougle CJ, Scahill L, Handen B, Johnson CR, Stigler KA, Bearss K, Swiezy NB, Aman MG. Predictors and moderators of parent training efficacy in a sample of children with autism spectrum disorders and serious behavioral problems. Journal of Autism and Developmental Disorders. 42: 1037-44. PMID 21822762 DOI: 10.1007/s10803-011-1338-2  0.32
2012 Grondhuis SN, Aman MG. Assessment of anxiety in children and adolescents with autism spectrum disorders Research in Autism Spectrum Disorders. 6: 1345-1365. DOI: 10.1016/j.rasd.2012.04.006  1
2011 Farmer CA, Arnold LE, Bukstein OG, Findling RL, Gadow KD, Li X, Butter EM, Aman MG. The treatment of severe child aggression (TOSCA) study: Design challenges. Child and Adolescent Psychiatry and Mental Health. 5: 36. PMID 22074813 DOI: 10.1186/1753-2000-5-36  1
2011 Tobiasova Z, van der Lingen KH, Scahill L, Leckman JF, Zhang Y, Chae W, McCracken JT, McDougle CJ, Vitiello B, Tierney E, Aman MG, Arnold LE, Katsovich L, Hoekstra PJ, Volkmar F, et al. Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. Journal of Child and Adolescent Psychopharmacology. 21: 555-64. PMID 22070180 DOI: 10.1089/cap.2010.0134  0.36
2011 Marcus RN, Owen R, Manos G, Mankoski R, Kamen L, McQuade RD, Carson WH, Corey-Lisle PK, Aman MG. Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study. Journal of Child and Adolescent Psychopharmacology. 21: 229-36. PMID 21663425 DOI: 10.1089/cap.2009.0121  1
2011 Hollway JA, Aman MG. Sleep correlates of pervasive developmental disorders: a review of the literature. Research in Developmental Disabilities. 32: 1399-421. PMID 21570809 DOI: 10.1016/j.ridd.2011.04.001  1
2011 Matlock ST, Aman MG. Development of the Adult Scale of Hostility and Aggression: Reactive-Proactive (A-SHARP). American Journal On Intellectual and Developmental Disabilities. 116: 130-41. PMID 21381948 DOI: 10.1352/1944-7558-116.2.130  1
2011 Hollway JA, Aman MG. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Research in Developmental Disabilities. 32: 939-62. PMID 21296553 DOI: 10.1016/j.ridd.2010.12.035  1
2011 Farmer CA, Aman MG. Aripiprazole for the treatment of irritability associated with autism. Expert Opinion On Pharmacotherapy. 12: 635-40. PMID 21294670 DOI: 10.1517/14656566.2011.557661  1
2011 Farmer CA, Aman MG. Aggressive behavior in a sample of children with autism spectrum disorders Research in Autism Spectrum Disorders. 5: 317-323. DOI: 10.1016/j.rasd.2010.04.014  1
2010 Arnold LE, Farmer C, Kraemer HC, Davies M, Witwer A, Chuang S, DiSilvestro R, McDougle CJ, McCracken J, Vitiello B, Aman MG, Scahill L, Posey DJ, Swiezy NB. Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. Journal of Child and Adolescent Psychopharmacology. 20: 83-93. PMID 20415603 DOI: 10.1089/cap.2009.0022  1
2010 Chowdhury M, Aman MG, Scahill L, Swiezy N, Arnold LE, Lecavalier L, Johnson C, Handen B, Stigler K, Bearss K, Sukhodolsky D, McDougle CJ. The Home Situations Questionnaire-PDD version: factor structure and psychometric properties. Journal of Intellectual Disability Research : Jidr. 54: 281-91. PMID 20377705 DOI: 10.1111/j.1365-2788.2010.01259.x  0.36
2010 McCracken JT, Aman MG, McDougle CJ, Tierney E, Shiraga S, Whelan F, Arnold LE, Posey D, Ritz L, Vitiello B, Scahill L. Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. Journal of Child and Adolescent Psychopharmacology. 20: 1-5. PMID 20166790 DOI: 10.1089/cap.2009.0059  1
2010 Farmer CA, Aman MG. Psychometric properties of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP). Research in Developmental Disabilities. 31: 270-80. PMID 19854027 DOI: 10.1016/j.ridd.2009.09.014  1
2009 Aman MG, McDougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, Stigler KA, Bearss K, Butter E, Swiezy NB, Sukhodolsky DD, Ramadan Y, Pozdol SL, Nikolov R, Lecavalier L, et al. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry. 48: 1143-54. PMID 19858761 DOI: 10.1097/CHI.0b013e3181bfd669  1
2009 Ghuman JK, Aman MG, Lecavalier L, Riddle MA, Gelenberg A, Wright R, Rice S, Ghuman HS, Fort C. Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. Journal of Child and Adolescent Psychopharmacology. 19: 329-39. PMID 19702485 DOI: 10.1089/cap.2008.0137  1
2009 Johnson CR, Butter EM, Handen BL, Sukhodolsky DG, Mulick J, Lecavalier L, Aman MG, Arnold LE, Scahill L, Swiezy N, Sacco K, Stigler KA, McDougle CJ. Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials. Journal of Intellectual & Developmental Disability. 34: 230-8. PMID 19681003 DOI: 10.1080/13668250903074471  1
2009 Esbensen AJ, Greenberg JS, Seltzer MM, Aman MG. A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. Journal of Autism and Developmental Disorders. 39: 1339-49. PMID 19434487 DOI: 10.1007/s10803-009-0750-3  1
2009 Farmer CA, Aman MG. Development of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP). Research in Developmental Disabilities. 30: 1155-67. PMID 19375274 DOI: 10.1016/j.ridd.2009.03.001  1
2009 Scahill L, Aman MG, McDougle CJ, Arnold LE, McCracken JT, Handen B, Johnson C, Dziura J, Butter E, Sukhodolsky D, Swiezy N, Mulick J, Stigler K, Bearss K, Ritz L, et al. Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 39: 720-9. PMID 19096921 DOI: 10.1007/s10803-008-0675-2  1
2009 Nikolov RN, Bearss KE, Lettinga J, Erickson C, Rodowski M, Aman MG, McCracken JT, McDougle CJ, Tierney E, Vitiello B, Arnold LE, Shah B, Posey DJ, Ritz L, Scahill L. Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 39: 405-13. PMID 18791817 DOI: 10.1007/s10803-008-0637-8  1
2009 Aman MG, Hollway JA, Leone S, Masty J, Lindsay R, Nash P, Arnold LE. Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children. Research in Developmental Disabilities. 30: 386-96. PMID 18768293 DOI: 10.1016/j.ridd.2008.07.004  1
2009 Jahromi LB, Kasari CL, McCracken JT, Lee LS, Aman MG, McDougle CJ, Scahill L, Tierney E, Arnold LE, Vitiello B, Ritz L, Witwer A, Kustan E, Ghuman J, Posey DJ. Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. Journal of Autism and Developmental Disorders. 39: 395-404. PMID 18752063 DOI: 10.1007/s10803-008-0636-9  1
2009 Karabekiroglu K, Aman MG. Validity of the aberrant behavior checklist in a clinical sample of toddlers. Child Psychiatry and Human Development. 40: 99-110. PMID 18600444 DOI: 10.1007/s10578-008-0108-7  1
2008 Aman MG, Farmer CA, Hollway J, Arnold LE. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America. 17: 713-38, vii. PMID 18775366 DOI: 10.1016/j.chc.2008.06.009  1
2008 Scahill L, Aman MG, McCracken JT, McDougle CJ, Vitiello B. Beware of over-interpreting negative trials. Journal of Autism and Developmental Disorders. 38: 1609-10. PMID 18594960 DOI: 10.1007/s10803-008-0581-7  0.32
2008 Aman MG, Hollway JA, McDougle CJ, Scahill L, Tierney E, McCracken JT, Arnold LE, Vitiello B, Ritz L, Gavaletz A, Cronin P, Swiezy N, Wheeler C, Koenig K, Ghuman JK, et al. Cognitive effects of risperidone in children with autism and irritable behavior. Journal of Child and Adolescent Psychopharmacology. 18: 227-36. PMID 18582177 DOI: 10.1089/cap.2007.0133  1
2008 Sukhodolsky DG, Scahill L, Gadow KD, Arnold LE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Williams White S, Lecavalier L, Vitiello B. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. Journal of Abnormal Child Psychology. 36: 117-28. PMID 17674186 DOI: 10.1007/s10802-007-9165-9  1
2007 Aman MG, Benson BA, Farmer CA, Hall KL, Malone KM. Project MED: effects of a Medication EDucation booklet series for individuals with intellectual disabilities. Intellectual and Developmental Disabilities. 45: 33-45. PMID 17428125 DOI: 10.1352/1934-9556(2007)45[33:PMEOAM]2.0.CO;2  1
2007 Jensen PS, Youngstrom EA, Steiner H, Findling RL, Meyer RE, Malone RP, Carlson GA, Coccaro EF, Aman MG, Blair J, Dougherty D, Ferris C, Flynn L, Green E, Hoagwood K, et al. Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. Journal of the American Academy of Child and Adolescent Psychiatry. 46: 309-22. PMID 17314717 DOI: 10.1097/chi.0b013e31802f1454  1
2007 Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, et al. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biological Psychiatry. 61: 538-44. PMID 17276750 DOI: 10.1016/j.biopsych.2006.09.028  1
2007 Wagner A, Lecavalier L, Arnold LE, Aman MG, Scahill L, Stigler KA, Johnson CR, McDougle CJ, Vitiello B. Developmental disabilities modification of the Children's Global Assessment Scale. Biological Psychiatry. 61: 504-11. PMID 17276748 DOI: 10.1016/j.biopsych.2007.01.001  0.36
2007 Pandina GJ, Bilder R, Harvey PD, Keefe RSE, Aman MG, Gharabawi G. Risperidone and Cognitive Function in Children With Disruptive Behavior Disorders Biological Psychiatry. 62: 226-234. PMID 17210137 DOI: 10.1016/j.biopsych.2006.09.036  1
2007 Tierney E, Aman M, Stout D, Pappas K, Arnold LE, Vitiello B, Scahill L, McDougle C, McCracken J, Wheeler C, Martin A, Posey D, Shah B. Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study. Psychopharmacology. 191: 149-57. PMID 17123125 DOI: 10.1007/s00213-006-0604-z  0.36
2007 Lam KS, Aman MG. The Repetitive Behavior Scale-Revised: independent validation in individuals with autism spectrum disorders. Journal of Autism and Developmental Disorders. 37: 855-66. PMID 17048092 DOI: 10.1007/s10803-006-0213-z  1
2007 Anderson GM, Scahill L, McCracken JT, McDougle CJ, Aman MG, Tierney E, Arnold LE, Martin A, Katsovich L, Posey DJ, Shah B, Vitiello B. Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biological Psychiatry. 61: 545-50. PMID 16730335 DOI: 10.1016/j.biopsych.2006.02.032  0.36
2006 Lindsay RL, Eugene Arnold L, Aman MG, Vitiello B, Posey DJ, McDougle CJ, Scahill L, Pachler M, McCracken JT, Tierney E, Bozzolo D. Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study. Journal of Intellectual & Developmental Disability. 31: 204-9. PMID 17178532 DOI: 10.1080/13668250601006924  0.32
2006 Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B, Ghuman J, Ritz L, Vitiello B. A prospective open trial of guanfacine in children with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology. 16: 589-98. PMID 17069547 DOI: 10.1089/cap.2006.16.589  1
2006 Arnold LE, Aman MG, Cook AM, Witwer AN, Hall KL, Thompson S, Ramadan Y. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry. 45: 1196-205. PMID 17003665 DOI: 10.1097/01.chi.0000231976.28719.2a  1
2006 Pandina GJ, Aman MG, Findling RL. Risperidone in the management of disruptive behavior disorders. Journal of Child and Adolescent Psychopharmacology. 16: 379-92. PMID 16958564 DOI: 10.1089/cap.2006.16.379  1
2006 Scahill L, McDougle CJ, Williams SK, Dimitropoulos A, Aman MG, McCracken JT, Tierney E, Arnold LE, Cronin P, Grados M, Ghuman J, Koenig K, Lam KS, McGough J, Posey DJ, et al. Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 45: 1114-23. PMID 16926619 DOI: 10.1097/01.chi.0000220854.79144.e7  1
2006 Williams SK, Scahill L, Vitiello B, Aman MG, Arnold LE, McDougle CJ, McCracken JT, Tierney E, Ritz L, Posey DJ, Swiezy NB, Hollway J, Cronin P, Ghuman J, Wheeler C, et al. Risperidone and adaptive behavior in children with autism. Journal of the American Academy of Child and Adolescent Psychiatry. 45: 431-9. PMID 16601648 DOI: 10.1097/01.chi.0000196423.80717.32  1
2006 Lecavalier L, Aman MG, Scahill L, McDougle CJ, McCracken JT, Vitiello B, Tierney E, Arnold LE, Ghuman JK, Loftin RL, Cronin P, Koenig K, Posey DJ, Martin A, Hollway J, et al. Validity of the autism diagnostic interview-revised. American Journal of Mental Retardation : Ajmr. 111: 199-215. PMID 16597187 DOI: 10.1352/0895-8017(2006)111[199:VOTADI]2.0.CO;2  1
2006 Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Research in Developmental Disabilities. 27: 254-89. PMID 16002261 DOI: 10.1016/j.ridd.2005.03.003  0.76
2006 Aman MG, Handen B. Reactions to "Ethical challenges and complexities of including people with intellectual disability as participants in research" by Dr Teresa Iacono Journal of Intellectual and Developmental Disability. 31: 180-182. DOI: 10.1080/13668250600876400  1
2006 Aman MG. Dr. Aman replies [4] Journal of Clinical Psychiatry. 67: 2031-2032.  1
2005 Lord C, Wagner A, Rogers S, Szatmari P, Aman M, Charman T, Dawson G, Durand VM, Grossman L, Guthrie D, Harris S, Kasari C, Marcus L, Murphy S, Odom S, et al. Challenges in evaluating psychosocial interventions for Autistic Spectrum Disorders. Journal of Autism and Developmental Disorders. 35: 695-708; discussion . PMID 16496206 DOI: 10.1007/s10803-005-0017-6  1
2005 Aman MG. Treatment planning for patients with autism spectrum disorders. The Journal of Clinical Psychiatry. 66: 38-45. PMID 16401149  1
2005 Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzalez NM, Swiezy NB, et al. Acute and long-term safety and tolerability of risperidone in children with autism. Journal of Child and Adolescent Psychopharmacology. 15: 869-84. PMID 16379507 DOI: 10.1089/cap.2005.15.869  1
2005 Vitiello B, Davies M, Arnold LE, McDougle CJ, Aman M, McCracken JT, Scahill L, Tierney E, Posey DJ, Swiezy NB, Koenig K. Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone. Journal of Clinical Psychopharmacology. 25: 565-9. PMID 16282839  0.36
2005 Neef NA, Bicard DF, Endo S, Coury DL, Aman MG. Evaluation of pharmacological treatment of impulsivity in children with attention deficit hyperactivity disorder. Journal of Applied Behavior Analysis. 38: 135-46. PMID 16033162 DOI: 10.1901/jaba.2005.116-02  1
2005 McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. The American Journal of Psychiatry. 162: 1142-8. PMID 15930063 DOI: 10.1176/appi.ajp.162.6.1142  1
2005 Neef NA, Marckel J, Ferreri SJ, Bicard DF, Endo S, Aman MG, Miller KM, Jung S, Nist L, Armstrong N. Behavioral assessment of impulsivity: a comparison of children with and without attention deficit hyperactivity disorder. Journal of Applied Behavior Analysis. 38: 23-37. PMID 15898472 DOI: 10.1901/jaba.2005.146-02  1
2005 Aman MG, Lam KS, Van Bourgondien ME. Medication patterns in patients with autism: temporal, regional, and demographic influences. Journal of Child and Adolescent Psychopharmacology. 15: 116-26. PMID 15741793 DOI: 10.1089/cap.2005.15.116  0.76
2005 Vitiello B, Aman MG, Scahill L, McCracken JT, McDougle CJ, Tierney E, Davies M, Arnold LE. Research knowledge among parents of children participating in a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry. 44: 145-9. PMID 15689727 DOI: 10.1097/00004583-200502000-00006  0.36
2004 Aman MG. Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder. Seminars in Pediatric Neurology. 11: 225-8. PMID 15575418 DOI: 10.1016/j.spen.2004.07.006  1
2004 Brown EC, Aman MG, Lecavalier L. Empirical classification of behavioral and psychiatric problems in children and adolescents with mental retardation. American Journal of Mental Retardation : Ajmr. 109: 445-55. PMID 15471511 DOI: 10.1352/0895-8017(2004)109<445:ECOBAP>2.0.CO;2  1
2004 Aman MG, Gharabawi GM. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone. The Journal of Clinical Psychiatry. 65: 1197-210. PMID 15367046 DOI: 10.4088/JCP.v65n0907  1
2004 Aman MG, Binder C, Turgay A. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Journal of Child and Adolescent Psychopharmacology. 14: 243-54. PMID 15319021 DOI: 10.1089/1044546041649020  1
2004 Lindsay RL, Leone S, Aman MG. Discontinuation of risperidone and reversibility of weight gain in children with disruptive behavior disorders. Clinical Pediatrics. 43: 437-44. PMID 15208748 DOI: 10.1177/000992280404300504  1
2004 Martin A, Scahill L, Anderson GM, Aman M, Arnold LE, McCracken J, McDougle CJ, Tierney E, Chuang S, Vitiello B. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. The American Journal of Psychiatry. 161: 1125-7. PMID 15169706 DOI: 10.1176/appi.ajp.161.6.1125  0.36
2004 Shultz J, Aman M, Kelbley T, LeClear Wallace C, Burt DB, Primeaux-Hart S, Loveland K, Thorpe L, Bogos ES, Timon J, Patti P, Tsiouris J. Evaluation of screening tools for dementia in older adults with mental retardation. American Journal of Mental Retardation : Ajmr. 109: 98-110. PMID 15000667 DOI: 10.1352/0895-8017(2004)109<98:EOSTFD>2.0.CO;2  1
2004 Hollander E, Phillips A, King BH, Guthrie D, Aman MG, Law P, Owley T, Robinson R. Impact of recent findings on study design of future autism clinical trials. Cns Spectrums. 9: 49-56. PMID 14999175  1
2004 Aman MG, Novotny S, Samango-Sprouse C, Lecavalier L, Leonard E, Gadow KD, King BH, Pearson DA, Gernsbacher MA, Chez M. Outcome measures for clinical drug trials in autism. Cns Spectrums. 9: 36-47. PMID 14999174  1
2003 Esbensen AJ, Rojahn J, Aman MG, Ruedrich S. Reliability and validity of an assessment instrument for anxiety, depression, and mood among individuals with mental retardation. Journal of Autism and Developmental Disorders. 33: 617-29. PMID 14714931 DOI: 10.1023/B:JADD.0000005999.27178.55  1
2003 Arnold LE, Vitiello B, McDougle C, Scahill L, Shah B, Gonzalez NM, Chuang S, Davies M, Hollway J, Aman MG, Cronin P, Koenig K, Kohn AE, McMahon DJ, Tierney E. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry. 42: 1443-50. PMID 14627879 DOI: 10.1097/00004583-200312000-00011  1
2003 Lindsay RL, Aman MG. Pharmacologic therapies aid treatment for autism. Pediatric Annals. 32: 671-6. PMID 14606217  1
2003 Aman MG, Lam KS, Collier-Crespin A. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. Journal of Autism and Developmental Disorders. 33: 527-34. PMID 14594332  0.76
2003 Rojahn J, Aman MG, Matson JL, Mayville E. The Aberrant Behavior Checklist and the Behavior Problems Inventory: convergent and divergent validity. Research in Developmental Disabilities. 24: 391-404. PMID 12951135 DOI: 10.1016/S0891-4222(03)00055-6  1
2003 Aman MG, Buican B, Arnold LE. Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. Journal of Child and Adolescent Psychopharmacology. 13: 29-40. PMID 12804124 DOI: 10.1089/104454603321666171  1
2002 Langworthy-Lam KS, Aman MG, Van Bourgondien ME. Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. Journal of Child and Adolescent Psychopharmacology. 12: 311-21. PMID 12625991 DOI: 10.1089/104454602762599853  0.36
2002 Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. The American Journal of Psychiatry. 159: 1337-46. PMID 12153826 DOI: 10.1176/appi.ajp.159.8.1337  1
2002 McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, et al. Risperidone in children with autism and serious behavioral problems. The New England Journal of Medicine. 347: 314-21. PMID 12151468 DOI: 10.1056/NEJMoa013171  1
2002 Brown EC, Aman MG, Havercamp SM. Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education. Research in Developmental Disabilities. 23: 45-60. PMID 12071395 DOI: 10.1016/S0891-4222(01)00091-9  1
2000 Aman MG, Collier-Crespin A, Lindsay RL. Pharmacotherapy of disorders in mental retardation European Child and Adolescent Psychiatry. 9. PMID 11140785 DOI: 10.1007/s007870070023  1
2000 Aman MG, Langworthy KS. Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders Journal of Autism and Developmental Disorders. 30: 451-459. PMID 11098883 DOI: 10.1023/A:1005559725475  1
2000 Aman MG, Armstrong SA. Regarding secretin for treating autistic disorder [1] Journal of Autism and Developmental Disorders. 30: 71-72. PMID 10819123  1
1999 Aman MG, Eugene Arnold L, Armstrong SC. Review of serotonergic agents and perseverative behavior in patients with developmental disabilities Mental Retardation and Developmental Disabilities Research Reviews. 5: 279-289. DOI: 10.1002/(SICI)1098-2779(1999)5:4<279::AID-MRDD5>3.0.CO;2-6  1
1999 Aman MG, Madrid A. Atypical antipsychotics in persons with developmental disabilities Mental Retardation and Developmental Disabilities Research Reviews. 5: 253-263. DOI: 10.1002/(SICI)1098-2779(1999)5:4<253::AID-MRDD2>3.0.CO;2-R  1
1998 Shultz JM, Aman MG, Rojahn J. Psychometric evaluation of a measure of cognitive decline in elderly people with mental retardation. Research in Developmental Disabilities. 19: 63-71. PMID 9472135 DOI: 10.1016/S0891-4222(97)00029-2  1
1997 Reiss S, Aman MG. The international consensus process on psychopharmacology and intellectual disability. Journal of Intellectual Disability Research : Jidr. 41: 448-55. PMID 9430048  1
1997 Aman MG. Recent Studies in Psychopharmacology in Mental Retardation International Review of Research in Mental Retardation. 21: 113-146. DOI: 10.1016/S0074-7750(08)60278-5  1
1997 Reiss S, Aman MG. The international consensus process on psychopharmacology and intellectual disability Journal of Intellectual Disability Research. 41: 448-455.  1
1997 DeWitt MB, Aman MG, Rojahn J. Effects of Reinforcement Contingencies on Performance of Children with Mental Retardation and Attention Problems Journal of Developmental and Physical Disabilities. 9: 101-115.  1
1996 Aman MG, Tassé MJ, Rojahn J, Hammer D. The Nisonger CBRF: A child behavior rating form for children with developmental disabilities Research in Developmental Disabilities. 17: 41-57. PMID 8750075 DOI: 10.1016/0891-4222(95)00039-9  1
1996 Sarphare G, Aman MG. Parent- and self-ratings of anxiety in children with mental retardation: Agreement levels and test-retest reliability Research in Developmental Disabilities. 17: 27-39. PMID 8750074 DOI: 10.1016/0891-4222(95)00035-6  1
1996 Aman MG. Stimulant drugs in the developmental disabilities revisited Journal of Developmental and Physical Disabilities. 8: 347-365. DOI: 10.1007/BF02578400  1
1995 Aman MG, Burrow WH, Wolford PL. The aberrant behavior checklist-community: Factor validity and effect of subject variables for adults in group homes American Journal On Mental Retardation. 100: 283-292. PMID 8554775  1
1995 Aman MG, Sarphare G, Burrow WH. Psychotropic drugs in group homes: Prevalence and relation to demographic/psychiatric variables American Journal On Mental Retardation. 99: 500-509. PMID 7779345  1
1995 Aman MG, Wolford PL. Consumer satisfaction with involvement in drug research: A social validity study Journal of the American Academy of Child and Adolescent Psychiatry. 34: 940-945. PMID 7649965  1
1995 Einfeld SL, Aman M. Issues in the taxonomy of psychopathology in mental retardation Journal of Autism and Developmental Disorders. 25: 143-167. PMID 7559282 DOI: 10.1007/BF02178501  1
1994 Pearson DA, Aman MG. Ratings of hyperactivity and developmental indices: Should clinicians correct for developmental level? Journal of Autism and Developmental Disorders. 24: 395-411. PMID 7525533 DOI: 10.1007/BF02172125  1
1994 Aman MG, Rojahn J. The psychometric characteristics of the preschool behavior questionnaire in preschoolers with developmental handicaps Journal of Developmental and Physical Disabilities. 6: 311-325. DOI: 10.1007/BF02578418  1
1993 Aman MG. Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities Annals of Clinical Psychiatry. 5: 171-188. PMID 7904217  1
1992 Marshburn EC, Aman MG. Factor validity and norms for the Aberrant Behavior Checklist in a community sample of children with mental retardation Journal of Autism and Developmental Disorders. 22: 357-373. PMID 1383187 DOI: 10.1007/BF01048240  1
1991 Aman MG, Turbott SH. Prediction of clinical response in children taking methylphenidate Journal of Autism and Developmental Disorders. 21: 211-228. PMID 1864828 DOI: 10.1007/BF02284761  1
1991 Aman MG. Pharmacotherapy in the developmental disabilites: New developments Australia and New Zealand Journal of Developmental Disabilities. 17: 183-199. DOI: 10.1080/07263869100034401  1
1991 Aman MG. Review and evaluation of instruments for assessing emotional and behavioural disorders Australia and New Zealand Journal of Developmental Disabilities. 17: 127-145. DOI: 10.1080/07263869100034351  1
1990 Glasspoole LA, Aman MG. Knowledge, attitudes, and happiness of nurses working with gerontological patients Journal of Gerontological Nursing. 16: 11-14. PMID 2303670  1
1990 Aman MG. Considerations in the use of psychotropic drugs in elderly mentally retarded persons Journal of Mental Deficiency Research. 34. PMID 2182880  1
1989 Aman MG, Kern RA. Review of fenfluramine in the treatment of the developmental disabilities Journal of the American Academy of Child and Adolescent Psychiatry. 28: 549. PMID 2670881  1
1988 Glasspoole LA, Aman MG. Atttitudes and knowledge of gerontological nurses toward psychotropic drugs Gerontologist. 28: 667-671. PMID 3229652  1
1988 Aman M. Letters to the editor Journal of the American Academy of Child and Adolescent Psychiatry. 27: 821-822. PMID 3198577  1
1988 Aman MG, White AJ. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents Journal of Autism and Developmental Disorders. 18: 355-366. PMID 3170454 DOI: 10.1007/BF02212192  1
1987 Aman MG, Singh NN, Fitzpatrick J. The relationship between nurse characteristics and perceptions of psychotropic medications in residential facilities for the retarded Journal of Autism and Developmental Disorders. 17: 511-523. PMID 3680153 DOI: 10.1007/BF01486967  1
1987 Aman MG. Overview of pharmacotherapy: Current status and future directions Journal of Mental Deficiency Research. 31: 121-130. PMID 2887660  1
1987 Mitchell EA, Aman MG, Turbott SH, Manku M. Clinical Characteristics and Serum Essential Fatty Acid Levels in Hyperactive Children Clinical Pediatrics. 26: 406-411. PMID 2439249 DOI: 10.1177/000992288702600805  1
1986 Aman MG, Turbott SH. Incidental learning, distraction, and sustained attention in hyperactive and control subjects Journal of Abnormal Child Psychology. 14: 441-455. PMID 3760349 DOI: 10.1007/BF00915437  1
1986 Aman MG, Singh NN. A critical appraisal of recent drug research in mental retardation: The Coldwater studies Journal of Mental Deficiency Research. 30: 203-216. PMID 2878082  1
1985 Sandberg S, Aman M. Comment on "hyperactivity: Nature of the syndrome and its natural history", Journal of Autism and Developmental Disorders. 15: 229-233. PMID 3997749 DOI: 10.1007/BF01531608  1
1985 Aman M. City-wide survey of drug patterns among non-institutionalised retarded persons New Zealand Medical Journal. 98: 509. PMID 3859783  1
1985 Aman MG, Singh NN. Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment Journal of Mental Deficiency Research. 29: 187-195. PMID 2863380  1
1985 Aman MG. Drugs in mental retardation: Treatment or tragedy? Australia and New Zealand Journal of Developmental Disabilities. 11: 215-226. DOI: 10.3109/13668258508998641  1
1985 White TJR, Aman MG. Pimozide treatment in disruptive severely retarded patients Australasian Psychiatry. 19: 92-94. DOI: 10.3109/00048678509158820  1
1984 Aman MG, White AJ, Field C. Chlorpromazine effects on stereotypic and conditioned behaviour of severely retarded patients - a pilot study Journal of Mental Deficiency Research. 28: 253-260. PMID 6396416 DOI: 10.1111/J.1365-2788.1984.TB01018.X  1
1984 Aman MG, Vamos M, Werry JS. Effects of methylphenidate in normal adults with reference to drug action in hyperactivity Australian and New Zealand Journal of Psychiatry. 18: 86-88. PMID 6380485 DOI: 10.3109/00048678409161040  1
1984 Aman MG. Hyperactivity: Nature of the syndrome and its natural history Journal of Autism and Developmental Disorders. 14: 39-56. PMID 6368521 DOI: 10.1007/BF02408554  1
1984 Aman MG. Mechanism for testing operant conditioning and body rocking in developmental disabilities Perceptual and Motor Skills. 58: 751-756. PMID 6206470  1
1982 Aman MG, Singh NN. Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior Applied Research in Mental Retardation. 3: 345-358. PMID 7168571 DOI: 10.1016/S0270-3092(82)80002-7  1
1982 Aman MG, Werry JS. Children's reading disorders: Problems of definition and a two-year follow-up Australian Paediatric Journal. 18: 268-272. PMID 7165590  1
1982 Aman MG. Stimulant drug effects in developmental disorders and hyperactivity - Toward a resolution of disparate findings Journal of Autism and Developmental Disorders. 12: 385-398. PMID 6131061 DOI: 10.1007/BF01538326  1
1982 Aman MG, Werry JS. Methylphenidate and diazepam in severe reading retardation Journal of the American Academy of Child and Adolescent Psychiatry. 21: 31-37.  1
1981 Aman MG, Wakeman P. A simple system for control of the continuous performance test in psychopharmacological research Progress in Neuro-Psychopharmacology. 4: 621-626. PMID 7220677 DOI: 10.1016/0364-7722(81)90104-1  1
1981 Singh NN, Aman MG. Mental retardation: State of the field in New Zealand Applied Research in Mental Retardation. 2: 115-127. PMID 7052751 DOI: 10.1016/0270-3092(81)90046-1  1
1981 Singh NN, Aman MG. Effects of thioridazine dosage on the behavior of severely mentally retarded persons American Journal of Mental Deficiency. 85: 580-587. PMID 7023237  1
1980 Aman MG, Mayhew JM. Consistency of cognitive and motor performance measures over two years in reading retarded children. Perceptual and Motor Skills. 50: 1059-65. PMID 7413379 DOI: 10.2466/pms.1980.50.3c.1059  1
1980 Aman MG. Psychotropic drugs and learning problems - a selective review Journal of Learning Disabilities. 13: 87-97. PMID 7391681  1
1980 Werry JS, Aman MG, Diamond E. Imipramine and methylphenidate in hyperactive children Journal of Child Psychology and Psychiatry and Allied Disciplines. 21: 27-35. PMID 7358801  1
1980 Hillas J, Somerfield S, Wilson J, Aman M. Azatadine maleate in perennial allergic rhinitis: effects on clinical symptoms and choice reaction time British Journal of Clinical Pharmacology. 10: 573-577. PMID 7008821 DOI: 10.1111/j.1365-2125.1980.tb00513.x  1
1980 Aman MG, Singh NN. The usefulness of thioridazine for treating childhood disorders - fact or folklore? American Journal of Mental Deficiency. 84: 331-338. PMID 6986772  1
1979 Aman MG. Cognitive, social, and other correlates of specific reading retardation Journal of Abnormal Child Psychology. 7: 153-168. PMID 469109 DOI: 10.1007/BF00918896  1
1978 Werry JS, Aman MG. Dietary control of hyperkinesis New Zealand Medical Journal. 88: 297-298. PMID 281634  1
1976 Werry JS, Aman MG. The reliability and diagnostic validity of the physical and neurological examination for soft signs (PANESS) Journal of Autism and Childhood Schizophrenia. 6: 253-262. PMID 1036492 DOI: 10.1007/BF01543465  1
1976 Werry JS, Aman MG, Lampen E. Haloperidol and methylphenidate in hyperactive children Acta Paedopsychiatrica. 42: 26-40. PMID 775883  1
1975 Aman MG, Werry JS. The effects of methylphenidate and haloperidol on the heart rate and blood pressure of hyperactive children with special reference to time of action Psychopharmacologia. 43: 163-168. PMID 1103207 DOI: 10.1007/BF00421019  1
1975 Werry JS, Aman MG. Methylphenidate and Haloperidol in Children: Effects on Attention, Memory, and Activity Archives of General Psychiatry. 32: 790-795. PMID 1093506 DOI: 10.1001/archpsyc.1975.01760240118009  1
1974 Aman MG, Sprague RL. The State-Dependent Effects of Methylphenidate and Dextroamphetamine Journal of Nervous and Mental Disease. 158: 268-279. PMID 4819605  1
Show low-probability matches.